Markers of DNA damage and risk of second malignancy following chemotherapy | Project | FP3-BIOMED 1 | CORDIS | European Commission

Follow the latest news and projects about COVID-19 and the European Commission's coronavirus response.

CORDIS
EU research results

Programme(s)

FP3-BIOMED 1 - Specific research and technological development programme (EEC) in the field of biomedicine and health, 1990-1994

Coordinator

International Agency for Research on Cancer

Address

150 Cours Albert Thomas
69372 Lyon
France

Share this page

Download

Last update: 18 February 1994
Record number: 19900

Permalink: https://cordis.europa.eu/project/id/BMH11134

© European Union, 2021

JavaScript is disabled on your browser.

CORDIS website requires JavaScript enabled in order to work properly. Please enable JavaScript.

JavaScript est désactivé dans votre navigateur.

Le site web de CORDIS nécessite l’activation de JavaScript pour fonctionner correctement. Veuillez activer JavaScript.

JavaScript está desactivado en su navegador.

El sitio web de CORDIS requiere tener activado JavaScript para funcionar correctamente. Por favor, active JavaScript.

JavaScript ist in Ihrem Browser deaktiviert.

Für die fehlerfreie Verwendung der CORDIS-Website muss JavaScript aktiviert sein. Bitte aktivieren Sie JavaScript.

JavaScript è disabilitato sul tuo browser

Il sito web di CORDIS prevede che JavaScript sia abilitato per funzionare correttamente. Si prega di abilitare JavaScript.

Obsługa JavaScript jest wyłączona w Twojej przeglądarce.

Aby witryna CORDIS działała poprawnie, obsługa JavaScript musi być włączona. Włącz obsługę JavaScript.